The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization-Reference-Cited by-同舟云学术

The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization

Published:2020-01-20 Issue:3 Volume:13 Page:545-557
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Schussek Sophie,Bernasconi Valentina,Mattsson Johan,Wenzel Ulf Alexander,Strömberg Anneli,Gribonika Inta,Schön Karin,Lycke Nils Y.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41385-020-0253-2.pdf

Reference80 articles.

1. Kollmann, T. R., Kampmann, B., Mazmanian, S. K., Marchant, A. & Levy, O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity 46, 350–363 (2017).

2. Zhang, X., Zhivaki, D. & Lo-Man, R. Unique aspects of the perinatal immune system. Nat. Rev. Immunol. 17, 495–507 (2017).

3. Saso, A. & Kampmann, B. Vaccine responses in newborns. Semin. Immunopathol. 39, 627–642 (2017).

4. Morris, M. C. & Surendran, N. Neonatal vaccination: challenges and intervention strategies. Neonatology 109, 161–169 (2016).

5. Kilich, E. & Anthony, M. Rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation. Arch. Dis. Child. Fetal Neonatal Ed. 100, F465 (2015).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of protective immune responses at respiratory mucosal sites;Human Vaccines & Immunotherapeutics;2024-07-02

2. Mechanisms of antibody mediated immunity – Distinct in early life;The International Journal of Biochemistry & Cell Biology;2024-07

3. Optimization of Soluble Expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD Fusion Proteins as Candidates for COVID-19 Intranasal Vaccines;2024-06-14

4. Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit;Antiviral Research;2023-12

5. Recent advances in enterotoxin vaccine adjuvants;Current Opinion in Immunology;2023-12